BWX Technologies (BWXT) Expected to Announce Earnings on Monday

BWX Technologies (NYSE:BWXT) is projected to issue its Q4 2025 results after the market closes on Monday, February 23rd. Analysts expect the company to announce earnings of $0.91 per share and revenue of $837.4680 million for the quarter. Parties can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Monday, February 23, 2026 at 5:00 PM ET.

BWX Technologies Trading Up 1.7%

BWX Technologies stock opened at $200.31 on Monday. BWX Technologies has a 12-month low of $84.21 and a 12-month high of $220.57. The company has a debt-to-equity ratio of 1.21, a current ratio of 1.71 and a quick ratio of 1.62. The stock has a market capitalization of $18.31 billion, a PE ratio of 60.15, a price-to-earnings-growth ratio of 3.22 and a beta of 0.83. The firm has a 50 day simple moving average of $192.65 and a 200-day simple moving average of $185.22.

Insider Transactions at BWX Technologies

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of the firm’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $203.26, for a total value of $2,032,600.00. Following the completion of the transaction, the chief executive officer directly owned 177,594 shares in the company, valued at $36,097,756.44. This trade represents a 5.33% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.47% of the company’s stock.

Institutional Investors Weigh In On BWX Technologies

A number of institutional investors have recently bought and sold shares of the business. Invesco Ltd. increased its holdings in shares of BWX Technologies by 60.1% in the 3rd quarter. Invesco Ltd. now owns 2,549,150 shares of the technology company’s stock valued at $469,987,000 after purchasing an additional 956,770 shares during the period. Select Equity Group L.P. purchased a new position in BWX Technologies during the second quarter valued at approximately $68,902,000. Orion Porfolio Solutions LLC increased its stake in BWX Technologies by 1,353.1% in the 2nd quarter. Orion Porfolio Solutions LLC now owns 363,757 shares of the technology company’s stock valued at $52,403,000 after buying an additional 338,723 shares during the period. Orbis Allan Gray Ltd acquired a new position in BWX Technologies in the 2nd quarter valued at approximately $42,504,000. Finally, Balyasny Asset Management L.P. lifted its position in BWX Technologies by 7,375.7% in the 3rd quarter. Balyasny Asset Management L.P. now owns 168,801 shares of the technology company’s stock worth $31,122,000 after buying an additional 166,543 shares in the last quarter. 94.39% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on BWXT shares. Truist Financial set a $205.00 price target on BWX Technologies in a research report on Friday, January 9th. Northland Securities set a $225.00 target price on BWX Technologies in a report on Tuesday, November 4th. CJS Securities upgraded shares of BWX Technologies to a “strong-buy” rating in a research report on Friday, December 12th. Weiss Ratings lowered shares of BWX Technologies from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Monday, January 26th. Finally, Zacks Research raised shares of BWX Technologies from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, January 21st. Three investment analysts have rated the stock with a Strong Buy rating, five have given a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, BWX Technologies presently has an average rating of “Moderate Buy” and a consensus price target of $199.20.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.